US Food and Drug Administration (FDA) officials asserted at a 26 April Generic Drug Forum (GDF) that firms with weak quality cultures are more susceptible to submit abbreviated new drug applications ...

"For example, the computer in [Pan's] quality unit area did not have controls to restrict access and prevent unauthorized changes to data files and folders," FDA writes. In light of these issues, FDA ...